Swenja Kröller‐Schön

The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats

Sebastian Steven, Matthias Oelze, Alina Hanf et al. · Redox Biology · 2017 · 305 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity

Matthias Oelze, Swenja Kröller‐Schön, Philipp Welschof et al. · PLoS ONE · 2014 · 292 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effects of noise on vascular function, oxidative stress, and inflammation: mechanistic insight from studies in mice

Thomas Münzel, Andreas Daiber, Sebastian Steven et al. · European Heart Journal · 2017 · 271 citations · Full text

Veterinary Medicine, Pathobiology, Physiology +15

Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension

Johanna Helmstädter, Katie Frenis, Konstantina Filippou et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2019 · 247 citations · Full text

Veterinary Medicine, Endocrinology, Pharmacology +17

Molecular Mechanisms of the Crosstalk Between Mitochondria and NADPH Oxidase Through Reactive Oxygen Species—Studies in White Blood Cells and in Animal Models

Swenja Kröller‐Schön, Sebastian Steven, Sabine Kossmann et al. · Antioxidants and Redox Signaling · 2013 · 245 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17